Lu Jiang

Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial

Pengpeng Xu, Di Fu, Jianyong Li et al. · The Lancet Haematology · 2019 · 50 citations

Medicine, Oncology, Pharmacology +14

Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study

Pengpeng Xu, Zi‐Yang Shi, Ying Qian et al. · The Lancet Healthy Longevity · 2022 · 36 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma

Lu Jiang, Zhaohui Gu, Zi‐Xun Yan et al. · Blood · 2014 · 34 citations

Medicine, Molecular Genetics, Oncology +14

Pharmacological mechanism of Shenlingbaizhu formula against experimental colitis

Wei Yu, Guo‐Liang Wang, Chang Lu et al. · Phytomedicine · 2022 · 29 citations

Life Sciences, Immunology, Nutritional Sciences +14

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy

Zi‐Xun Yan, Li Li, Di Fu et al. · Frontiers of Medicine · 2023 · 28 citations

Medicine, Immunology, Oncology +12